| Name | Able Home Health |
|---|---|
| Location | 209 Main Street, Suite 104, Saco, Maine |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology |
| Medicare ID | 207074 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 4002, 4005, 4038, 4043, 4046, 4061, 4062, 4064, 4072, 4073, 4074, 4083, 4084, 4090, 4092, 4098, 4101, 4102, 4103, 4105, 4106, 4107 |
| NPI Number | 1255581666 |
| Organization Name | VICKI L. DOUGHERTY/ABLE TO STAY HOME CARE |
| Doing Business As | ABLE TO STAY HOME CARE |
| Address | 209 Main St, Suite 104, Saco, ME 04072 |
| Phone Number | 207-282-1699 |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
| NPI Number | 1457653461 |
| Organization Name | ABLE HOME HEALTH, INC |
| Doing Business As | ABLE HOME HEALTH |
| Address | 209 Main St Ste 104, Saco, ME 04072 |
| Phone Number | 207-282-1699 |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
| Quality Rating: |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 97.4 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 94.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 87.7 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.7 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 88.3 | 79.6 |
| How often patients got better at getting in and out of bed | 93.8 | 81.1 |
| How often patients got better at bathing | 84.4 | 82.3 |
| How often patients’ breathing improved | 91.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 83.9 | 75 |
| How often home health patients had to be admitted to the hospital | 12.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 94.9 | 94 |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
The patient survey data of Able Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 91 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 80 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 91 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 92 | 78 |
News Archive
Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.
What are the risks to an unborn child if a woman contracts COVID-19 while pregnant, and how can doctors identify which pregnancies are at greater risk of adverse outcomes if a pregnant mother tests positive?
Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.
Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.
› Verified 8 days ago
Mainehealth Care At Home Location: 15 Industrial Park Road, Saco, Maine 4072 Ratings: Phone: (207) 284-4566 | |
Able Home Health Location: 209 Main Street, Suite 104, Saco, Maine 4072 Ratings: Phone: (207) 282-1699 |